Metraipolis › archive › dc_440938d030a2

Rho GTPases in cancer resistance: mechanisms, vulnerabilities, and therapeutic opportunities — Europe PMC PMID:42093646

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42093646
DOI
10.1042/bst20250097
License (as archived)
solo-consultazione
Archived
2026-11-02T23:31:09.596Z
SHA-256 of the archived text
6f12ebd650006d70c82041546f4e500647f56eb5a558e105a1f53ebc08909133
Stable URL of this page
https://metraipolis.com/documento/dc_440938d030a2

How to cite

Rho GTPases in cancer resistance: mechanisms, vulnerabilities, and therapeutic opportunities — Europe PMC PMID:42093646 — Europe PMC (en), https://europepmc.org/article/MED/42093646 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_440938d030a2 (Metraipolis archive dc_440938d030a2, sha256 6f12ebd650006d70c82041546f4e500647f56eb5a558e105a1f53ebc08909133)
BibTeX
@misc{dc440938d030a2,
  title = {Rho GTPases in cancer resistance: mechanisms, vulnerabilities, and therapeutic opportunities — Europe PMC PMID:42093646},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42093646},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_440938d030a2; sha256 6f12ebd650006d70c82041546f4e500647f56eb5a558e105a1f53ebc08909133},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42093646. Agents can read the archived copy with the MCP tool read_document.